《新股消息》檸萌影視(09857.HK)下限27.75元定價 一手中籤率100%
騰訊(00700.HK)持股的內地劇集製作公司檸萌影視(09857.HK)公布招股結果,每股發售價定為27.75元,為招股價範圍27.75至33.3元的下限,香港公開發售認購不足,僅錄約0.81倍認購。該股將於明日(10日)掛牌。每手100股計,一手中籤率100%,人人有份。聯席保薦人為摩根士丹利及中金。
是次上市引入兩名基石投資者,包括嘉實及海瀾集團,合共認購707.18萬股公司股份,佔緊隨全球發售完成後公司已發行股本約1.96%。
公司上市料淨集資約3.23億元,約10%將分配至進一步擴展IP庫:約50%分配至進一步製作版權劇:
約15%分配至開拓新興商機;約15%分配至尋求戰略投資及收購機會;約10%用作一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.